Open what she sent.

AKAnna Keller, 47 · Hypertension, prediabetes, LDL 162 mg/dl · 14 documents, read 16 September 2026

Open what she sent.

Answered on 16 September 2026

It arrived as a sheet, not as a chat. Her question stands in her own words at the top, agreed with her before it was sent, and Mosaic answered nothing of it: whether she should stop the tablet would change her plan, and that is your decision. Visit 16.09.2026

Underneath stands what you would otherwise look up: her plan says to report new muscle pain and to keep taking the tablet unless the pain is severe, the CK before the start was 96 U/l, and in 2024 the aches were in both thighs and resolved two weeks after stopping. Lab 08.05.2026 Visit 14.03.2024 Eur Heart J

Three replies are drafted from that, and each one says what it would set in motion. Nothing reaches her until you send it, and it goes under your name.

Patient requestDraft, for your signature

Muscle aches on day 14

Her question in her words, agreed before it was sent
The plan, the CK before the start, and what happened in 2024
Three drafted replies, each with what it sets in motion

Nothing reaches her until you send it, and it goes under your name

From the patient record3 of 14 documents

Visit note, today's consultation (draft), 16 September 2026Clinical note
Laboratory report, 8 May 2026Laboratory
Visit note, simvastatin stopped, 14 March 2024Clinical note

1.Statin-associated muscle symptoms: impact on statin therapy. European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.European Heart Journal. 2015;36:1012-1022. Stroes ES, Thompson PD, Corsini A, et al.Guideline
SummaryDefines statin-associated muscle symptoms as symmetric proximal muscle pain, weakness or stiffness beginning within weeks to months of a statin start and improving within weeks of withdrawal; CK is usually normal or mildly raised. Management: withdraw, wait for symptoms to resolve, then rechallenge with the same or a different statin at a lower dose or alternate-day dosing; most patients tolerate a second statin. Non-statin therapy for those who cannot.
Source
Issuing body: European Atherosclerosis Society Consensus Panel
Published: May 2015
Grading system: Consensus statement
Scope
Target population: Patients with muscle symptoms on statin therapy
Scope: Definition, assessment, management, rechallenge

What would you like to ask next?

1Does atorvastatin interact with her current medication?

This is a sample workspace. Click one of the questions. To ask your own questions, request access.

Anna Keller, 47Mosaic